Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.
about
Real-time PCR in clinical microbiology: applications for routine laboratory testing.Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dyeRole of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants.CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremiaPreemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.Laboratory assays for Epstein-Barr virus-related disease.Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.Epstein-Barr virus serology and PCR: conflicting results in an immunocompetent host. A case report and review of literature.Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimensLytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients.Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning.Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipientsMarked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab.Rapid progression of Epstein-Barr-virus-positive gastric diffuse large B-cell lymphoma during chemoradiotherapy: a case report.Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation.Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection.Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
P2860
Q27472851-2F237C9E-3278-4744-8C48-83F0CFE177F2Q34217149-AC7B18D0-2FF2-44B5-BE76-A304FDAF948EQ34769887-1ACCB389-45B4-4C1B-BB49-06ADAABA11FAQ35001143-98CDD243-B271-4465-8500-7521FE13CFADQ35803089-3BBC3294-1664-41D9-9D93-B3FDC1C68C33Q36389306-BF987763-9428-46DD-B4F5-457AC6187645Q36537637-AE86AAA3-D42D-4B0A-81A9-7202F3AC2A9EQ37192117-B55C4571-5183-4782-8182-3B724300E344Q37726624-35077597-018E-4149-A0F9-C3912802CC9CQ38219320-5FA30F94-5641-40AD-81A8-3BD62C1483CBQ39694961-EC82A581-88E0-4327-9CEC-682740408D41Q40056807-64679116-1099-45D1-AFC2-AFA0E872B2F4Q40279797-B739434C-02F4-4278-860C-8926825483AFQ40511369-1F39ADAB-0046-421D-8D65-9B386171B274Q41811942-C13CB07B-54FE-4F55-B728-BA28CC8B5C89Q41865790-7DE00289-33F2-4F34-B61C-ED4D8729A45DQ42154867-71D4F065-DB03-4B54-BD0B-9B47CA454D7CQ42272334-958131B6-F48B-4769-9997-E9F098178FDCQ44150295-853B6964-0EFB-404F-9B54-F8C07A979FC5Q45341287-94C51460-D2CC-459D-AC66-0B311B7B4C34Q45358118-C248ACE9-FB1B-4123-8111-D147EF688B18Q45361212-601490FB-DF0E-4293-8973-3367516159CCQ45368771-FA2F37DD-8A3F-47E5-AF5D-F662C533BD78Q45450388-493F1AE6-0592-4105-9F7A-6B1CB2B8810EQ50775253-04EFF17A-C2C7-4FB7-B0F0-16A2308CF229
P2860
Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Molecular quantification of vi ...... eic stem cell transplantation.
@ast
Molecular quantification of vi ...... eic stem cell transplantation.
@en
type
label
Molecular quantification of vi ...... eic stem cell transplantation.
@ast
Molecular quantification of vi ...... eic stem cell transplantation.
@en
prefLabel
Molecular quantification of vi ...... eic stem cell transplantation.
@ast
Molecular quantification of vi ...... eic stem cell transplantation.
@en
P2093
P2860
P1476
Molecular quantification of vi ...... eic stem cell transplantation.
@en
P2093
Boucher CA
Cornelissen JJ
Gratama JW
Löwenberg B
Niesters HG
Osterhaus AD
Thijsen SF
Verdonck LF
P2860
P304
P356
10.1046/J.1365-2141.2001.02789.X
P407
P577
2001-06-01T00:00:00Z